A new U.N. AIDS agency report says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global effort ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...

Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable ...

Publix has had to manage several recalls involving both meat and non-meat products since the start of the year.

In addition to finding these dyes in brightly colored processed foods, the researchers also found them in more muted foods ...

The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...

The justices said they were not ruling on the legality of specific firing plans but simply allowing the administration to ...

Looming threats to pharmaceuticals and the drug supply chain have brought fresh attention to onshoring. Experts say ...

The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s work, current ...

The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...

News about Food and Drug Administration, including commentary and archival articles published in The New York Times.